These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT, Swedish Brain Tumour Study Group. Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940 [Abstract] [Full Text] [Related]
11. A computational dosimetry tool for the study of tumor doses and skin toxicities in BNCT. Gossio S, Carando DG, González SJ. Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S145-8. PubMed ID: 19386508 [Abstract] [Full Text] [Related]
12. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008). H-Stenstam B. Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284 [No Abstract] [Full Text] [Related]
14. Enhanced blood boron concentration estimation for BPA-F mediated BNCT. Kortesniemi M, Seppälä T, Auterinen I, Savolainen S. Appl Radiat Isot; 2004 Nov; 61(5):823-7. PubMed ID: 15308151 [Abstract] [Full Text] [Related]
15. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M. Radiat Res; 1994 Jun; 138(3):435-42. PubMed ID: 8184019 [Abstract] [Full Text] [Related]
17. Dynamic infrared imaging of cutaneous melanoma and normal skin in patients treated with BNCT. Santa Cruz GA, Bertotti J, Marín J, González SJ, Gossio S, Alvarez D, Roth BM, Menéndez P, Pereira MD, Albero M, Cubau L, Orellano P, Liberman SJ. Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S54-8. PubMed ID: 19380232 [Abstract] [Full Text] [Related]
18. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI, Chung HP, Liu HM, Chi CW, Lui WY. Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [Abstract] [Full Text] [Related]